Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP323706.RALXgaOyEByD42YJ3dIlCsZjvUaDUSgjQg_ZaxGdrvHg8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP323706.RALXgaOyEByD42YJ3dIlCsZjvUaDUSgjQg_ZaxGdrvHg8130_assertion type Assertion NP323706.RALXgaOyEByD42YJ3dIlCsZjvUaDUSgjQg_ZaxGdrvHg8130_head.
- NP323706.RALXgaOyEByD42YJ3dIlCsZjvUaDUSgjQg_ZaxGdrvHg8130_assertion description "[In vitro studies showed more expression of thrombin-activatable fibrinolysis inhibitor in small cell carcinoma than in adenocarcinoma cell lines and more expression in lung cancer cell lines sensitive to anti-cancer agents than in resistant cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323706.RALXgaOyEByD42YJ3dIlCsZjvUaDUSgjQg_ZaxGdrvHg8130_provenance.
- NP323706.RALXgaOyEByD42YJ3dIlCsZjvUaDUSgjQg_ZaxGdrvHg8130_assertion evidence source_evidence_literature NP323706.RALXgaOyEByD42YJ3dIlCsZjvUaDUSgjQg_ZaxGdrvHg8130_provenance.
- NP323706.RALXgaOyEByD42YJ3dIlCsZjvUaDUSgjQg_ZaxGdrvHg8130_assertion SIO_000772 15224354 NP323706.RALXgaOyEByD42YJ3dIlCsZjvUaDUSgjQg_ZaxGdrvHg8130_provenance.
- NP323706.RALXgaOyEByD42YJ3dIlCsZjvUaDUSgjQg_ZaxGdrvHg8130_assertion wasDerivedFrom befree-20150227 NP323706.RALXgaOyEByD42YJ3dIlCsZjvUaDUSgjQg_ZaxGdrvHg8130_provenance.
- NP323706.RALXgaOyEByD42YJ3dIlCsZjvUaDUSgjQg_ZaxGdrvHg8130_assertion wasGeneratedBy ECO_0000203 NP323706.RALXgaOyEByD42YJ3dIlCsZjvUaDUSgjQg_ZaxGdrvHg8130_provenance.